| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
National Cancer Research Institute, Toxicological Evaluation [C. B., E. P., E. L.] and Environmental Epidemiology [R. F., M. N., R. P.], 16132 Genoa; Pneumology, Ospedale S. Bartolomeo, 19038 Sarzana [P. A. C.]; Pneumology, AO Villa Scassi, 16149 Genoa [C. S.]; Department of Health Sciences, University of Genoa, 16132 Genoa [P. G. C.]; and Ospedale S. Pietro e Paolo, ASL11, 13011 Borgosesia and S. Maurgeri Foundation Institute for Research and Care, 27100 Pavia [L. M.], Italy
We evaluated the frequency of micronuclei (MN) in peripheral blood lymphocytes of patients with pleural malignant mesotelioma (MM), lung cancer, benign respiratory diseases, and healthy controls. A significant increased frequency of MN was observed in patients with MM in comparison with all the other groups (median, 11.4 binucleated MN/1000 binucleated cells versus 5.1, 6.1, and 6.2, respectively). No association was found between MN and asbestos exposure. Recently, genetic susceptibility associated with asbestos exposure has been recognized in the development of MM. The presence of high frequency of MN in peripheral blood lymphocytes of patients with MM could represent a useful index of individual susceptibility to this tumor.
This article has been cited by other articles:
![]() |
L. Migliore, S. Molinu, A. Naccarati, M. Mancuso, A. Rocchi, and G. Siciliano Evaluation of cytogenetic and DNA damage in mitochondrial disease patients: effects of coenzyme Q10 therapy Mutagenesis, January 1, 2004; 19(1): 43 - 49. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |